Immunomodulation by cocaine and ketamine in postnatal rats.
The abuse of cocaine (COC) in combination with ketamine (KET) among pregnant women was shown to be high. Transplacental exposure is not the only route by which a newborn may be exposed to these agents, but they can also distribute into breast milk. Chronic COC exposure is associated with immunological modulation in human and animal models. The effect of sub-chronic exposure to COC and KET alone and in combination on the developing immune system was assessed in neonatal male Sprague-Dawley (SD) rats. To simulate the route of exposure during lactation, newborn male rats were treated orally with saline, COC alone (20 mg/kg), KET alone (50 mg/kg), or KET (50 mg/kg) followed 15 min later by COC (20 mg/kg) from days 1 to 21 of life. Pups were sacrificed 30 min following the last treatment. Total circulating leukocyte and lymphocyte counts were decreased with relative neutrophilia, while spleen/body weight ratio and IgM antibody response to sheep red blood cells (SRBCs) were increased in animals treated with COC. Moreover, treatment with COC alone increased serum interleukin 10 (IL-10) concentration; however, it did not affect serum interferon gamma (IFN-gamma) concentration. On the other hand, KET treatment did not produce any significant change of any of these parameters. However, when co-administered with COC, the immunomodulatory effects of COC were prevented. COC caused a significant increase in serum corticosterone concentration that KET effectively prevented. Lack of significant change of plasma and tissue concentrations of norcocaine (NC) suggested no role for COC metabolism in COC-induced immunomodulation. However, the results of this study indicate that COC-induced immunomodulatory reactions and their prevention by KET most likely occurred through neuroendocrinal mechanisms.
Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, Room I-655, Newark, NJ 07103-2714, USA.
Hany Z
HZ
Rofael
Rita M
RM
Turkall
Mohamed S
MS
Abdel-Rahman
D000276:Adjuvants, Immunologic / Q000633:toxicity*; D000410:Alanine Transaminase / Q000097:blood; D000778:Anesthetics, Dissociative / Q000276:immunology / Q000633:toxicity*; D000818:Animals; D000831:Animals, Newborn; D001772:Blood Cell Count; D003042:Cocaine / Q000276:immunology / Q000633:toxicity*; D003345:Corticosterone / Q000097:blood; D005260:Female; D007075:Immunoglobulin M / Q000097:blood; D007371:Interferon-gamma / Q000097:blood; D016753:Interleukin-10 / Q000097:blood; D007649:Ketamine / Q000276:immunology / Q000633:toxicity*; D008198:Lymph Nodes / Q000187:drug effects / Q000276:immunology; D008297:Male; D009294:Narcotics / Q000276:immunology / Q000633:toxicity*; D011247:Pregnancy; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013154:Spleen / Q000187:drug effects / Q000276:immunology; D019966:Substance-Related Disorders / Q000276:immunology; D013950:Thymus Gland / Q000187:drug effects / Q000276:immunology
D000276:Adjuvants, Immunologic; D000778:Anesthetics, Dissociative; D007075:Immunoglobulin M; D009294:Narcotics; D016753:Interleukin-10; D007649:Ketamine; D007371:Interferon-gamma; D000410:Alanine Transaminase; D003042:Cocaine; D003345:Corticosterone